UK Launches National Allergy Strategy - Summary - MDSpire

UK Launches National Allergy Strategy

First coordinated plan targets gaps in data and surveillance

  • April 28, 2026

  • 3 min

Share

Objective:

To address fragmented services and rising demand for allergy care in the UK, driven by increased prevalence and awareness.

Key Findings:
  • One in three people in the UK is affected by allergic disease.
  • Allergy accounts for around 6% of GP visits and 10% of the GP prescribing budget.
  • The prevalence of allergic rhinitis and eczema has trebled since the 1970s.
  • Hospital admissions for anaphylaxis increased threefold from 1998 to 2018.
  • The UK has one of the worst allergy rates in the world.
Interpretation:

The strategy aims to establish allergy as a major chronic condition in health policy, improve care consistency across various sectors, and address health inequalities.

Limitations:
  • Inconsistent care pathways and limited specialist capacity.
  • Gaps in data and surveillance hinder effective implementation.
  • Need for better coordination across sectors.
Conclusion:

The launch marks the beginning of a broader program to translate evidence into measurable improvements in allergy care across the UK, with a focus on health inequalities and workforce sustainability.

Original Source(s)

UK Launches National Allergy Strategy

  • April 28, 2026

Related Content

Staffing, Flexibility Top Nurses' List to Return

Two-thirds of former hospital nurses would consider coming back if workplace conditions improved, survey finds

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.